Papers
(The H4-Index of Nature Reviews Drug Discovery is 80. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
Improving circular RNA protein yields | 87 |
Pfizer buys Biohaven’s migraine drugs for $11.6 billion | 81 |
Neutralizing Zika virus | 80 |
Upcoming market catalysts in Q1 2023 | 80 |
Upcoming market catalysts in Q3 2022 | 80 |